76
66
Growth Score 76 in past quarter
-6 pts
Heat Score 66 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
266327
Novilla Pharmaceuticals develops patented drug delivery mechanisms for deeper penetration of established therapies.
- Eric Fossel: Chief Scientific Officer
Ajay Kori: Co-Founder and Managing Director
About the Company
Novilla Pharmaceuticals develops patented drug delivery mechanisms for deeper penetration of established therapies. The Opioid Epidemic is one of the most significant threats to public health facing the United States.
The company was founded in 2019 and is based in Arlington, Virginia with a laboratory in Cambridge, Massachusetts.